title: Intraprocedural thrombotic events: What's the real cost?
abstract: Intraprocedural thrombotic events (IPTE) during PCI occur in 4% of patients with NSTEACS and 12% of STEACS. IPTE increases hospital cost by $3,592. With an incidence of 4%, additional therapy to completely prevent IPTE in 100 patients would need to cost $144 to make it cost neutral. Further studies are necessary to determine cost-benefit of therapies to prevent IPTE such as cangrelor or newer P2Y12 inhibitors with more rapid onset.
authors.affiliation: Section of Interventional Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Lipinski
authors.affiliation: Section of Interventional Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, Washington, District of Columbia.
authors.forename: Lowell F
authors.initials: LF
authors.lastname: Satler
mesh_terms: D054058:Acute Coronary Syndrome / Q000601:surgery*; D005260:Female; D017721:Hospital Costs; D006801:Humans; D007431:Intraoperative Complications / Q000191:economics*; D008297:Male; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects*; D013927:Thrombosis / Q000191:economics*